|
Ingenuity Systems enable researchers to model, analyze and understand complex biological systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for biologists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies.
Ingenuity was founded in 1998 and is headquartered inRedwood City, California with offices in Germany, Switzerland, France, the United Kingdom, and Japan.
The Ingenuity Pathway Analysis product (IPA™) is a software application that enables researchers to model, analyze and understand the complex biological systems at the core of life science research. IPA is built on a foundation of extensive biological and chemical content that is manually extracted from the scientific literature by Ingenuity experts. The powerful combination of the content and tools within IPA allow users to gain rapid insight into their experimental data and gene sets, answer complex biological questions, and rationally plan the next step in their research quickly and reliably.
Key Features of the Content in IPA
Expert extraction – All relationships are manually curated and modeled by a team of Ph.D. scientists, and are supported by experimental evidence published in the peer reviewed literature
Breadth of knowledge – IPA stores millions of relationships between proteins, genes, complexes, cells, tissues, chemicals and diseases
Biological context – Strict content extraction and quality control protocols require inclusion of details regarding cell type, mutations, domains, species, tissues, type of modification, and more
Consistent modeling – Ingenuity’s proprietary ontology tools and protocols ensure consistent modeling of biological knowledge, enabling rapid development of computational solutions
Frequent updates – Quarterly updates provide customers with high-impact content from over 300 journals plus review articles, textbooks, external databases such as OMIM, GO and EntrezGene as well as manually curated pathways and drug/target/disease relationships
Visit the Ingenuity Systems websit [www.ingenuity.com]
|
